Canagliflozin in dogs: the evidence

What the aging-research databases and the canine literature hold for Canagliflozin (names searched: Canagliflozin). Compiled from DrugAge, the canine aging corpus and FDA CVM FOI summaries; nothing here is inferred.

Lifespan experiments in other species (DrugAge)

6 experiments recorded, by species: Mus musculus 6.

NIA Interventions Testing Program rows

SpeciesStrainDoseAge at startDurationSexMean lifespan Δ%Mean sig.Max lifespan Δ%Max sig.Source
Mus musculusUM-HET3180 ppm food (30 ppm bodyweight)7 monthsuntil deathFemale1NS1NSPMID 32990681
Mus musculusUM-HET3180 ppm food (30 ppm bodyweight)7 monthsuntil deathMale14S9SPMID 32990681
Mus musculusUM-HET3180 ppm food6 monthsuntil deathFemale-1NS4NSPMID 38753230
Mus musculusUM-HET3180 ppm food6 monthsuntil deathMale9S5NSPMID 38753230
Mus musculusUM-HET3180 ppm food16 monthsuntil deathFemale-6S-8NSPMID 38753230
Mus musculusUM-HET3180 ppm food16 monthsuntil deathMale14S4SPMID 38753230

Lifespan experiments in dogs (DrugAge)

DrugAge records no dog lifespan experiment for this compound.

Dog-equivalent doses (allometric starting points, not recommendations)

Method: FDA 2005 Km body-surface-area conversion; starting-point heuristic only.

No mg/kg dose in DrugAge to translate (doses reported as ppm of diet or a concentration).

Canine aging literature (Europe PMC corpus)

2 corpus records mention this compound.

Top hits in the core tier

FDA CVM FOI summaries for dog products

No FDA FOI summary for a dog product contains this ingredient (it is not a marketed veterinary product).

Evidence gaps reported by the dossier tool

Reproduce: intervention_dossier(compound="Canagliflozin") in dog-geroscience-mcp.